Un Underestimated Symptom of Aortic Stenosis

For the first time, this long term observational study on a large cohort of contemporary patients with aortic stenosis (AS), has shown syncope is an underestimated threat, associated with worse prognosis after surgical aortic valve replacement (SAVR).

¿Qué usar para medir funcionalmente una lesión coronaria en el contexto de estenosis aórtica severa?It is interesting to note that other symptoms or early signs of AS that will normally indicate SAVR (dyspnea, angina or ventricular function deterioration) are associated with significantly better prognosis after SAVR. Patients presenting syncope usually display a specific pathophysiologic phenotype characterized by a smaller aortic valve area, smaller cardiac cavities, and lower stroke volumes.

 

The decision to replace the aortic valve is not always easy and requires thorough risk/Benefit ratio assessment.


Read also: Clinical Events after Deferral of LAD Treatment Guided by FFR or iFR.


Cardinal symptoms that indicate SAVR are angina, cardiac failure and syncope; however, it remains unclear whether these symptoms convey increased risk after SAVR or whether early detection, even when subtle, should be emphasized in the clinical practice.

 

A total 625 patients with isolated AS receiving elective SAVR were prospectively enrolled in this long-term study.

 

Patients presenting syncope had significantly smaller ventricular diameters (p=0.02), as well as smaller atrial diameters.


Read also: How long should we wait with asymptomatic aortic stenosis and preserved LVEF?


They also had smaller valve areas (p=0.048) and lower stroke index volume.

 

After adjusting for variables, syncope was associated with over 100% increased mortality risk  (HR 2.27, p=0.04) at one year, and again, over 100% increased mortality risk (HR 2.11, p<0.001) at 10 years. On the contrary, dyspnea, angina or preoperatory ventricular failure were not associated with worse evolution after SAVR.

 

Original title: Syncope. The Underestimated Threat in Severe Aortic Stenosis.

Reference: Georg Goliasch et al. J Am Coll Cardiol Img 2019. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...